Nanobiosym Diagnostics Inc is categorized under Biological Products Manufacturers in Cambridge, MA and active since 2010.
Nanobiosym Diagnostics Inc was established in 2010, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact Chris Mott at the company’s single location by writing to 245 1st St # 18, Cambridge, Massachusetts MA 02142 or by phoning (330) 782-8206. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nanobiosym Diagnostics Inc |
| Contact Person: | Chris Mott |
| Address: | 245 1st St # 18, Cambridge, Massachusetts 02142 |
| Phone Number: | (330) 782-8206 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Nanobiosym Diagnostics Inc was started in 2010 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Chris Mott for inquiries that concern Nanobiosym Diagnostics Inc by calling the company number (330) 782-8206, as your correspondence is most welcome. Additionally, the physical location of the single location of Nanobiosym Diagnostics Inc can be found at the coordinates 42.363558,-71.078818 as well as the street address 245 1st St # 18 in Cambridge, Massachusetts 02142.
For its online presence, you may visit Nanobiosym Diagnostics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.